MAVACAMTEN Pharmacologic Class Indexing
- Class set ID
- a503caf3-be9b-4c49-b809-b508e4f167a8
- Version
- 1
- Effective date
- 20231003
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use CAMZYOS safely and effectively. See full prescribing information for CAMZYOS. CAMZYOS ® (mavacamten) capsules for oral use Initial U.S. Approval: 2022 | Myokardia, Inc. | 20250417 | 8 |